SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-047600
Filing Date
2005-03-11
Accepted
2005-03-11 13:52:37
Documents
12
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 INSPIRE PHARMACEUTICALS FORM 10-K d10k.htm 10-K 988996
2 AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY dex1040.htm EX-10.40 21141
3 AGREEMENT BETWEEN INSPIRE AND BARRY G. PEA dex1041.htm EX-10.41 73033
4 EMPLOYEE CONFIDENTIALITY, INVENTION ASSIGNMENT AND NON-COMPETE AGREEMENT dex1042.htm EX-10.42 27397
5 TRANSISTION AGREEMENT dex1043.htm EX-10.43 58979
6 EXCLUSIVE LICENSE AGREEMENT dex1044.htm EX-10.44 125098
7 FORM OF INSPIRE PHARMACEUTICALS EMPLOYEE STOCK OPTION AGREEMENT dex1056.htm EX-10.56 42841
8 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1757
9 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)/15D-14(A) dex311.htm EX-31.1 7780
10 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)/15D-14(A) dex312.htm EX-31.2 7809
11 CERTIFICATION OF CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 3566
12 CERTIFICATION OF CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 3569
  Complete submission text file 0001193125-05-047600.txt   1365170
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE
Type: 10-K | Act: 34 | File No.: 001-31577 | Film No.: 05674881
SIC: 2834 Pharmaceutical Preparations